Presented by Genentech and Neurocrine Biosciences
Presented by Hepatx Corporation
Presented by Lifescience Dynamics
Join this session to learn different approaches for incorporating the voices of underserved/marginalized communities in market research. We will explore how organizations can move towards greater inclusivity and diversity in their medical and advocacy efforts and examine our responsibility to accurately reflect the diversity of patients in every step of market research. Attendees will leave with practical insights and tools to promote health equity and close the gap. In this session, you will learn:
• Ways to incorporate voices of underserved communities in market research, challenges that come with that, and how to overcome those challenges.
• Ideas for how to holistically embed health equity using both primary and secondary data into patient journeys and launch plan strategies.
• How to engage with external stakeholders to support grassroots initiatives aimed at reducing health disparities that continue to affect many of our communities.
Presented by Genentech
Presented by Gilead
Presented by Myovant Sciences and ThinkGen
Whether you are optimizing messaging, informing clinical trial design, or mapping out the buying process, the outcomes are focused on the impact of various brand and clinical decisions on likely prescribing behavior – otherwise known as product demand.
But do we really treat each market research opportunity as an input to the next forecast? If you’re like most organizations, you put the focus on one major demand study to do all of the heavy lifting. What if there were a different way?
To wit, we introduce Demand Thinking™, an approach to research planning and design that can leverage the power of multiple market research projects to feed data points to your forecasting team throughout the program year. In this presentation, we will introduce the core concepts of Demand Thinking™ and provide examples of how you can introduce Demand Thinking™ elements into commonplace studies to fuel your brand forecast all year long.
Presented by APLUSA
Presented by 23andMe
Join Regeneron as they share their journey of adopting a narrative-based approach to uncover the elusive “why” behind data, enabling them to better understand the motivations and challenges faced by cancer patients. Despite a remote-first environment, the team was able to delve into patients’ intimate experiences with their disease, physicians, and treatment, leading to transformative insights for both patients’ lives and Regeneron’s key brands.
In this session, you will learn about:
• Techniques to maintain engagement and illumination in research and readout processes
• Strategies for uncovering the “why” behind the data
• The power of story-based research methodologies grounded in lived experiences to transcend remote barriers
Presented by Regeneron
Presented by Veritas est
Presented by HawkPartners and Pfizer
Presented by Teva Pharmaceuticals
Presented by BeiGene
Presented by Amgen, Gilead, Novo Nordisk and Regenxbio
Presented by 23andMe
Presented by Align Technology
Join Brandtrust to learn how they leveraged Narrative Inquiry – a proprietary narrative-based qualquant methodology – and strategic sample blending to go deeper on this complex topic and reveal actionable insights
that have the potential to dramatically reframe how we think about, and treat, mental health issues.
In this session, you will learn about:
• How pairing agile narrative-based qual-quant research methodologies with strategic sample blending can provide deeper, more actionable strategic insights
• How the general public thinks and feels about mental health today, in their own words
• The keys to building, repairing and supporting mental wellness, including barriers and nuances specific to gender associations
Presented by Brandtrust
By leveraging the power of the smartphone, it enables researchers to walk a mile in the shoes of the customer, both patients and physicians. It allows pharma to gain an understanding of the healthcare journey from their perspectives, as told by them, by documenting what really matters and how their experiences affect their daily lives and decision-making.
In this presentation, Research Partnership will explain how digital ethnography goes beyond traditional qualitative methods to explore the ‘unknowns’ and the ‘known unknowns’ using behavioral science principles. In addition, they will explore the potential opportunities for digital ethnography research in healthcare and share a range of case studies addressing a number of different objectives, including an award-winning project conducted with head and neck cancer patients.
Presented by Research Partnership
Presented by Day One
Presented by BioMarin, Gilead, Medtronic and Teva Pharmaceuticals
Meeting with a challenging medical diagnosis was hard, but not having an available treatment served a crushing blow to their hopes and aspirations for their child.
Following the adage, ‘where there is a will, there is a way’ they embarked on a life-changing journey that consisted of finding treatment, drug trial participation and, ultimately, founding a non-profit that embraced patient education and advocacy, and partnerships with pharmaceutical companies.
In this presentation they will share major milestones of their journey, remind pharmaceuticals of the ‘why’ of their work, and propose models that can help seed-fund academic research that can accelerate and reduce costs of new therapies.
Presented by Genentech and Neurocrine Biosciences